Your World of Legal Intelligence
 Canada | +1 (343) 700 0450

ViiV Healthcare Company v. Gilead Sciences Canada, Inc., 2020 FC 486

Judgment Cited authorities 26 Cited in 32 Precedent Map Related
Vincent
JurisdictionFederal Jurisdiction (Canada)
CourtFederal Court (Canada)
Citation2020 FC 486
Date06 April 2020
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
30 practice notes
  • Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, 2020 FC 816
    • Canada
    • Federal Court (Canada)
    • September 10, 2020
    ...Manufacturing Inc v 931409 Alberta Ltd (Central Alberta Hay Centre), 2010 FCA 188; ViiV Healthcare Company v Gilead Sciences Canada, Inc, 2020 FC 486 at para 56). It is now also applied in claim differentiation between independent claims (Camso Inc v Soucy International Inc, 2019 FC 255 at ......
  • Eli Lilly Canada Inc. v. Apotex Inc., 2020 FC 814
    • Canada
    • Federal Court (Canada)
    • September 10, 2020
    ...Manufacturing Inc v 931409 Alberta Ltd (Central Alberta Hay Centre), 2010 FCA 188; ViiV Healthcare Company v Gilead Sciences Canada, Inc, 2020 FC 486 at para 56). It is now also applied in claim differentiation between independent claims (Camso Inc v Soucy International Inc, 2019 FC 255 at ......
  • VIIV HEALTHCARE CO. V. GILEAD SCIENCES CANADA, INC.,
    • Canada
    • Court of Appeal (Canada)
    • June 16, 2021
    ...Manson J.). ViiV also appeals a summary judgment dismissing its patent infringement action against the respondent, Gilead (per Manson J.): 2020 FC 486. [2] For the reasons that follow, I would dismiss the appeals with costs. A. Background and the appeals from the interlocutory [3] The paten......
  • Deeproot Green Infrastructure, LLC v. Greenblue Urban North America Inc., 2023 FCA 185
    • Canada
    • Court of Appeal (Canada)
    • September 13, 2023
    ...if an essential element is missing or substituted with something else: ViiV Healthcare Company v. Gilead Sciences Canada, Inc., 2020 FC 486 at para. 175, aff’d 2021 FCA 122, leave to appeal denied [2021] S.C.C.A. No. 306. This is so even if the allegedly infringing device performs su......
    • Request a trial to view additional results
11 cases
  • Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, 2020 FC 816
    • Canada
    • Federal Court (Canada)
    • September 10, 2020
    ...Manufacturing Inc v 931409 Alberta Ltd (Central Alberta Hay Centre), 2010 FCA 188; ViiV Healthcare Company v Gilead Sciences Canada, Inc, 2020 FC 486 at para 56). It is now also applied in claim differentiation between independent claims (Camso Inc v Soucy International Inc, 2019 FC 255 at ......
  • Eli Lilly Canada Inc. v. Apotex Inc., 2020 FC 814
    • Canada
    • Federal Court (Canada)
    • September 10, 2020
    ...Manufacturing Inc v 931409 Alberta Ltd (Central Alberta Hay Centre), 2010 FCA 188; ViiV Healthcare Company v Gilead Sciences Canada, Inc, 2020 FC 486 at para 56). It is now also applied in claim differentiation between independent claims (Camso Inc v Soucy International Inc, 2019 FC 255 at ......
  • VIIV HEALTHCARE CO. V. GILEAD SCIENCES CANADA, INC.,
    • Canada
    • Court of Appeal (Canada)
    • June 16, 2021
    ...Manson J.). ViiV also appeals a summary judgment dismissing its patent infringement action against the respondent, Gilead (per Manson J.): 2020 FC 486. [2] For the reasons that follow, I would dismiss the appeals with costs. A. Background and the appeals from the interlocutory [3] The paten......
  • Deeproot Green Infrastructure, LLC v. Greenblue Urban North America Inc., 2023 FCA 185
    • Canada
    • Court of Appeal (Canada)
    • September 13, 2023
    ...if an essential element is missing or substituted with something else: ViiV Healthcare Company v. Gilead Sciences Canada, Inc., 2020 FC 486 at para. 175, aff’d 2021 FCA 122, leave to appeal denied [2021] S.C.C.A. No. 306. This is so even if the allegedly infringing device performs su......
    • Request a trial to view additional results
19 firm's commentaries
  • Canadian Patent Law 2022: A Year In Review
    • Canada
    • Mondaq Canada
    • January 16, 2023
    ...underlying action. This was despite acknowledging that Justice Manson, who decided ViiV Healthcare Company v Gilead Sciences Canada, Inc, 2020 FC 486 (the decision under appeal in 2021 FCA 122), reconsidered the issue and reached the opposite conclusion in Janssen Inc v Pharmascience Inc, 2......
  • IP Litigation 2020 Year In Review
    • Canada
    • Mondaq Canada
    • January 30, 2021
    ...JJA). 5. Canmar Foods Ltd v. TA Foods Ltd., 2019 FC 1233 (Justice Manson). 6. ViiV Healthcare Company v. Gilead Sciences Canada, Inc., 2020 FC 486 (Justice Manson); Gemak v. Jempak, 2020 FC 644 (Justice Lafrenière); and Flatwork Technologies, LLC (Powerblanket) v. Brierley, 2020 FC 997......
  • Federal Court Continues Recent Trend Of Granting Summary Judgment In Appropriate Patent Proceedings
    • Canada
    • Mondaq Canada
    • January 15, 2021
    ...v TA Foods Ltd. (2019 FC 1233)1, Gemak v Jempak Corporation (2020 FC 644)2, and Viiv Healthcare Company, v Gilead Sciences Canada Inc. (2020 FC 486)3) Accordingly, it appears that in the appropriate circumstances, summary judgment or summary trial is now a viable option to resolve patent di......
  • Patent Infringement Summary Judgment Trend Continues
    • Canada
    • Mondaq Canada
    • February 9, 2022
    ...Ciba v SNF, 2017 FCA 225 at para.77. 3. Apotex v Shire, 2021 FCA 52 at paras.60-77. 4. Canmar, 2019 FC 1233, Gemak, 2020 FC 644 and Viiv, 2020 FC 486 all dismissed proceedings on summary judgment for Read the original article on GowlingWLG.com The content of this article is intended to prov......
    • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT